300529 健帆生物
2024/03 - 三个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额507,095916,744883,8001,249,415957,489
投资活动产生之现金流量净额(839,268)(249,649)(305,901)(670,220)(341,106)
筹资活动产生之现金流量净额(93,209)(451,911)(365,934)165,175(313,028)
汇率变动对现金及现金等价物的影响(49)11(36)-0(36)
现金及现金等价物净增加/(减少)(425,430)215,195211,929744,370303,320
期初现金及现金等价物余额2,741,5432,526,3492,314,4201,570,0501,266,730
期末现金及现金等价物余额2,316,1132,741,5432,526,3492,314,4201,570,050